Coronavirus – COVID-19 Information and Resources for Researchers

A Message from the Vice President for Research

COVID-19 Daily Update: April 2nd, 2020

Tulane FAQs for Federal Grant Applicants and Award Recipients During the COVID-19 Pandemic https://tulane.app.box.com/s/165xai5tnty56zlby4d6r3qsnoo6dkgs

Federal grant funding details related to COVID-19: NIH/NSF Grant Funding Flexibility: https://tulane.box.com/s/w4o7kp16vwa92d1ff1yww16gqqiq67e2

Funding opportunities related to COVID-19:

• NIH: Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
• NIH: Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
• NSF Rapid Response proposals:https://www.nsf.gov/pubs/2020/nsf20052/nsf20052.pdf
• DOD: MTEC funding pre-announcement for Diagnostics, therapeutics, Disease modeling, Patient Monitoring
• MIT: Health Security and Pandemics Challenge ($1 million) Solution pitch due 6.18.2020
• NIH/NIDA: (NOSI) for Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (Risk factors for HIV-affected and Substance abuse disorder populations)
• BARDA:  https://beta.sam.gov/opp/1b46a4169fcb4902b9c4fcbb5bf981f7/view
• NIH: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-028.html
• NSF: https://www.nsf.gov/pubs/2020/nsf20055/nsf20055.jsp
• CDC: https://beta.sam.gov/opp/728e1131ef444abc880f63540a37c364/view?keywords=...
• DARPA’s FAQs encourages performers with research project ideas related to COVID-19 to respond to the Office-wide broad agency announcements (BAAs) for both the Defense Sciences Office (DSO) and Biological Technology Office (BTO), which both have open BAAs that can receive submissions at any time. The DSO and BTO Office-wide BAAs can be found at https://www.darpa.mil/work-with-us/office-wide-broad-agency-announcements
• HHS/Biomedical Advanced Research and Development Authority (BARDA): BARDA opened an easy broad agency announcement, an EZ-BAA, seeking diagnostics that utilize platforms already cleared by the FDA, with a viable plan to meet requirements for the FDA to consider emergency use authorization within 12 weeks.
• NIH/National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of General Medical Sciences (NIGMS): Administrative Supplementals Current grantees may be eligible to apply for an administrative supplemental. Contact your program officer to discuss proposed research on SARS-CoV-2/COVID-2019. If it is within the scope of your current grant, an administrative supplement is the best option to obtain additional funding. PA-18-591
• NIH/NIGMS: Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-025.html
• NIH/NIAID: Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease,  https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-034.html
• NIGMS Feedback Loop: https://loop.nigms.nih.gov/2020/03/urgent-competitive-revisions-to-nigms...
• AHRQ: Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19
• American Heart Association: Rapid Response Grants for Heart and Brain Focused Research related to COVID-19
• NIH: NOT-AI-20-034 Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID1 https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-034.html
• NIH: NOT-TR-20-011 Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-011.html
• NSF: On March 25, NSF released a Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19. NSF invites U.S.-based businesses to submit Phase I SBIR/STTR proposals focused on “the development and deployment of new technologies, products, processes, and services” that have the potential to help respond to COVID-19. The DCL highlights the following areas of research: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. The DCL is available at https://www.nsf.gov/pubs/2020/nsf20065/nsf20065.jsp?WT.mc_id=USNSF_25&WT...

Sponsor Guidance for federal applicants and grantees:

• NIH: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm
• NSF:  https://www.nsf.gov/news/special_reports/coronavirus/
• NEA: https://www.arts.gov/coronavirus
• NEH: https://www.neh.gov/news/information-neh-and-covid-19
• DOE: https://www.energy.gov/coronavirus-hub
• DoEd: https://www.ed.gov/coronavirus?src=feature
• DOJ:  Sends you to CDC: https://www.coronavirus.gov/
• OMB: Sends you to CDC; https://www.coronavirus.gov/
• LaBOR: https://regents.la.gov/covid19-response/
• DOD: https://basicresearch.defense.gov/COVID-19/Frequently-Asked-Questions/

Tulane University Guidance for Researchers during the COVID-19 Pandemic March 24, 2020: https://tulane.box.com/s/wv7dfwk030xlc2bbh2ho2fg630n4h3cu  

Tulane virologist Dr. Robert Garry explains origins of COVID-19: https://www.youtube.com/watch?v=YLykxJqTBpU

COVID-19 Public Town Hall: Tulane University School of Medicine: https://www.youtube.com/watch?v=7FEcFyOh3IM

Comprehensive summary of federal guidance and funding opportunities: https://intranet.research.tulane.edu/